Green Thumb Industries Reports Third Quarter 2022 Results
Green Thumb Industries reported financial results for Q3 2022, highlighting a 3% sequential and 12% year-over-year revenue increase to $261 million. The year-to-date revenue reached $758 million, marking a 17% rise. The company posted a GAAP net income of $10 million or $0.04 per share for the ninth consecutive quarter. Adjusted Operating EBITDA grew by 7% to $84 million, equating to 32% of revenue. Green Thumb also announced plans for RISE Express medical dispensaries in Florida, aiming to enhance consumer access.
- Revenue increased 12% year-over-year to $261 million.
- Year-to-date revenue rose 17% to $758 million.
- GAAP net income of $10 million for Q3.
- Adjusted Operating EBITDA grew by 7% to $84 million.
- Net income decreased from $20.2 million in Q3 2021 to $9.8 million in Q3 2022.
- Gross profit margin fell from 55.4% in Q3 2021 to 50.2% in Q3 2022.
- Comparable sales declined 1.6% on a base of 59 stores.
CHICAGO and VANCOUVER, British Columbia, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today reported its financial results for the third quarter ended September 30, 2022. Financial results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and all currency is in U.S. dollars.
Highlights for the third quarter and nine months ended September 30, 2022:
- Revenue increased
3% sequentially and12% year-over-year to$261 million . - Year-to-date 2022 revenue increased
17% to$758 million compared to the first nine months of 2021. - Ninth consecutive quarter of positive GAAP net income, delivering
$10 million or$0.04 per basic and diluted share. - Adjusted Operating EBITDA grew
7% sequentially to$84 million or32% of revenue. - Cash flow from operations of
$48 million net of income tax payments of$31 million for the quarter.
See definitions and reconciliation of non-GAAP measures elsewhere in this release.
Management Commentary
“We are proud to report record revenue and Adjusted Operating EBITDA for the quarter against a backdrop of higher inflation and greater economic uncertainty. Revenue increased
“As we near the end of 2022, we are optimistic about the future of the U.S. cannabis market and proud of Green Thumb’s leadership position in the industry. We continue to think about what is best for the American consumer, as demonstrated by the recent announcement of our plans to launch RISE Express medical dispensaries adjacent to Circle K locations in Florida. Looking ahead, our focus remains on execution, maintaining a strong balance sheet and making strategic investments in markets that will generate strong returns for our stakeholders over time,” concluded Kovler.
Recent Development
On October 19, 2022, subsequent to quarter end, the Company announced plans to expand its medical cannabis retail footprint in Florida through leasing arrangements with Circle K, the global convenience store retailer. Subject to regulatory approvals following construction, Green Thumb plans to launch its test and learn phase of the rollout in 2023, with approximately ten “RISE Express” branded medical dispensaries adjacent to Circle K stores in various Florida locations.
Through the exclusive agreement, Green Thumb can lease space adjacent to Circle K locations in Florida, where the retailer currently operates approximately 600 locations. The planned “RISE Express” stores will offer patients with a valid medical marijuana identification card expanded access to a selection of branded medical cannabis products including RYTHM premium flower, Dogwalkers pre-rolls, incredibles gummies and &Shine vapes.
Third Quarter 2022 Financial Overview
Total revenue for the third quarter of 2022 was
All 15 of Green Thumb’s state markets contributed to third quarter revenue: California, Colorado, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia. The Company continued to invest in expanding its cultivation and manufacturing capabilities across its footprint.
Gross profit for the third quarter of 2022 was
Total selling, general and administrative expenses for the third quarter were
Net income attributable to the Company for the third quarter of 2022 was
In the third quarter of 2022, EBITDA was
For additional information on these non-GAAP financial measures, see below under “Non-GAAP Financial Information.”
Balance Sheet and Liquidity
As of September 30, 2022, current assets were
Total basic and diluted weighted average shares outstanding for the three months ended September 30, 2022, were 237.0 million shares and 237.8 million shares, respectively.
Consumer Packaged Goods Business Development
- Green Thumb’s third quarter revenue included sales from its family of consumer brands including RYTHM, Dogwalkers, incredibles, Beboe, Doctor Solomon’s, Good Green and &Shine that were produced, distributed, and available in retail locations across the country.
- Good Green, the Company’s newest brand, has expanded to eight total markets with additional markets planned for later this year and in 2023.
- Consumer Packaged Goods gross revenue increased
5.9% sequentially.
Retail Business Development
- Green Thumb’s third quarter revenue included sales from 77 retail stores in the following states: California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.
- Overall retail revenue increased
3.6% quarter-over-quarter. - Comparable sales (stores open at least 12 months) declined
1.6% on a base of 59 stores as continued traffic and volume growth were more than offset by price compression. - Subsequent to quarter end, Green Thumb announced plans to expand its medical cannabis retail footprint in Florida through leasing arrangements with Circle K, the global convenience store retailer, as described above.
Capital Markets and Financing
On July 14, 2022, Green Thumb announced it exercised its right to extend the maturity date of its senior non-brokered debt by one year, from April 30, 2024 to April 30, 2025. The Company’s senior secured notes (the “Notes”), which have a total principal amount of approximately
Green Thumb in the Community
On August 25, 2022, the Company announced that RISE Dispensaries will serve as a premier sponsor of HeadCount’s Cannabis Voter Project, which aims to register and inform voters who support cannabis policy reform. Leading up to this year’s midterm elections, HeadCount and RISE Dispensaries have been teaming up to encourage voters to “Roll Up to the Polls” through Cannabis Voter Project resources now available at all RISE-branded locations and online at www.headcount.org/rise.
Non-GAAP Financial Information
This press release includes certain non-GAAP financial measures as defined by the U.S. Securities and Exchange Commission. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measure calculated and presented in accordance with GAAP are included in the financial schedules attached to this press release. This information should be considered as supplemental in nature and not as a substitute for, or superior to, any measure of performance prepared in accordance with GAAP.
Definitions
EBITDA: Earnings before interest, taxes, other income or expense and depreciation and amortization.
Adjusted Operating EBITDA: Earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash stock-based compensation, one-time transaction related expenses, or other non-operating costs.
Conference Call and Webcast
Green Thumb will host a conference call on Wednesday, November 2, 2022, at 5:00 pm ET to discuss its third quarter 2022 financial results for the quarter ended September 30, 2022. The earnings call may be accessed by dialing 844-883-3895 (Toll-Free) or 412-317-5797 (International). A live audio webcast of the call will also be available on the Investor Relations section of Green Thumb’s website at https://investors.gtigrows.com and will be archived for replay.
About Green Thumb Industries:
Green Thumb Industries Inc. (“Green Thumb”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles and RYTHM. The company also owns and operates rapidly growing national retail cannabis stores called RISE. Headquartered in Chicago, Illinois, Green Thumb has 17 manufacturing facilities, 77 open retail locations and operations across 15 U.S. markets. Established in 2014, Green Thumb employs approximately 3,800 people and serves millions of patients and customers each year. The company was named to Crain’s Chicago Business Fast 50 list in 2021 and 2022 and a Best Workplace by MG Retailer magazine in 2018, 2019 and 2021. More information is available at www.gtigrows.com.
Cautionary Note Regarding Forward-Looking Information
This press release contains statements that we believe are, or may be considered to be, “forward-looking statements.” All statements other than statements of historical fact included in this document regarding the prospects of our industry or our prospects, plans, financial position or business strategy may constitute forward-looking statements. In addition, forward-looking statements generally can be identified by the use of forward-looking words such as “may,” “will,” “expect,” “intend,” “estimate,” “foresee,” “opportunity,” “project,” “potential,” “risk,” “anticipate,” “believe,” “plan,” “forecast,” “continue,” “suggests” or “could” or the negative of these terms or variations of them or similar terms or expressions of similar meaning. Furthermore, forward-looking statements may be included in various filings that we make with the Securities and Exchange Commission (the “SEC”), or oral statements made by or with the approval of one of our authorized executive officers. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we cannot assure you that these expectations will prove to be correct. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements. These known and unknown risks include, without limitation: the impact of COVID-19; cannabis remains illegal under U.S. federal law, and enforcement of cannabis laws could change; the Company may be subject to action by the U.S. federal government; state regulation of cannabis is uncertain; the Company may be subject to heightened scrutiny by Canadian regulatory authorities; the Company may face limitations on ownership of cannabis licenses; the Company may become subject to U.S. Food and Drug Administration or the U.S. Bureau of Alcohol, Tobacco and Firearms; cannabis businesses are subject to applicable anti-money laundering laws and regulations and have restricted access to banking and other financial services; the Company lacks access to U.S. bankruptcy protections; the Company may face difficulties acquiring additional financing; the Company operates in a highly regulated sector and may not always succeed in complying fully with applicable regulatory requirements in all jurisdictions where it carries on business; the Company has limited trademark protections; the Company may face difficulties in enforcing its contracts; cannabis businesses are subject to unfavorable tax treatment; cannabis businesses may be subject to civil asset forfeiture; the Company is subject to proceeds of crime statutes; the Company faces exposure to fraudulent or illegal activity; the Company’s use of joint ventures may expose it to risks associated with jointly owned investments; the Company faces risks related to its products; the Company is dependent on the popularity of consumer acceptance of the Company’s brand portfolio; the Company’s business is subject to the risks inherent in agricultural operations; the Company faces risks related to its information technology systems and potential cyber-attacks and security breaches; the Company faces an inherent risk of product liability and similar claims; the Company’s products may be subject to product recalls; the Company may face unfavorable publicity or consumer perception; the Company faces intense competition; the Company’s voting control is concentrated; the Company’s capital structure and voting control may cause unpredictability; sales of substantial amounts of the Company’s Subordinate Voting Shares by our shareholders in the public market may have an adverse effect on the market price of the Subordinate Voting Shares; and the Company is governed by the corporate laws of British Columbia, Canada which in some cases have a different effect on shareholders than the laws in Delaware, United States. Further information on these and other potential factors that could affect the Company’s business and financial condition and the results of operations are included in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2021, and elsewhere in the Company’s filings with the SEC, which are available on the SEC’s website or at https://investors.gtigrows.com. Readers are cautioned not to place undue reliance on any forward-looking statements contained in this document, which reflect management’s opinions only as of the date hereof. Except as required by law, we undertake no obligation to revise or publicly release the results of any revision to any forward-looking statements. You are advised, however, to consult any additional disclosures we make in our reports to the SEC. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained in this document.
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.
Investor Contact:
Andy Grossman
EVP, Capital Markets & Investor Relations
InvestorRelations@gtigrows.com
312-471-6720
Media Contact:
MATTIO Communications
GTI@mattio.com
Source: Green Thumb Industries
| Green Thumb Industries Inc. | ||||||||||||
| Highlights from Unaudited Interim Condensed Consolidated Statements of Operations | ||||||||||||
| For the Three Months Ended September 30, 2022, June 30, 2022 and September 30, 2021 | ||||||||||||
| (Amounts Expressed in Thousands of United States Dollars, Except for Share Amounts) | ||||||||||||
| Three Months Ended | ||||||||||||
| September 30, 2022 | June 30, 2022 | September 30, 2021 | ||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||
| Revenues, Net of Discounts | $ | 261,194 | $ | 254,311 | $ | 233,677 | ||||||
| Cost of Goods Sold, Net | (129,954 | ) | (128,513 | ) | (104,159 | ) | ||||||
| Gross Profit | 131,240 | 125,798 | 129,518 | |||||||||
| Expenses: | ||||||||||||
| Selling, General, and Administrative | 82,479 | 63,535 | 71,449 | |||||||||
| Total Expenses | 82,479 | 63,535 | 71,449 | |||||||||
| Income (Loss) From Operations | 48,761 | 62,263 | 58,069 | |||||||||
| Other Income (Expense): | ||||||||||||
| Other Income (Expense), Net | (2,085 | ) | 5,583 | 8,125 | ||||||||
| Interest Income, Net | 1,085 | 624 | 328 | |||||||||
| Interest Expense, Net | (4,644 | ) | (5,399 | ) | (7,616 | ) | ||||||
| Total Other Income (Expense) | (5,644 | ) | 808 | 837 | ||||||||
| Income Before Provision for Income Taxes And Non-Controlling Interest | 43,117 | 63,071 | 58,906 | |||||||||
| Provision For Income Taxes | 32,969 | 38,340 | 37,320 | |||||||||
| Net Income Before Non-Controlling Interest | 10,148 | 24,731 | 21,586 | |||||||||
| Net Income Attributable To Non-Controlling Interest | 319 | 294 | 1,376 | |||||||||
| Net Income Attributable To Green Thumb Industries Inc. | $ | 9,829 | $ | 24,437 | $ | 20,210 | ||||||
| Net Income per Share - Basic | $ | 0.04 | $ | 0.11 | $ | 0.09 | ||||||
| Net Income per Share - Diluted | $ | 0.04 | $ | 0.10 | $ | 0.08 | ||||||
| Weighted Average Number of Shares Outstanding - Basic | 237,002,873 | 236,783,625 | 226,529,671 | |||||||||
| Weighted Average Number of Shares Outstanding - Diluted | 237,804,799 | 237,762,903 | 230,879,437 | |||||||||
| Green Thumb Industries Inc. | |||
| Highlights from the Unaudited Interim Condensed Consolidated Balance Sheet | |||
| (Amounts Expressed in Thousands of United States Dollars) | |||
| September 30, | |||
| 2022 | |||
| (Unaudited) | |||
| Cash and Cash Equivalents | $ | 147,258 | |
| Other Current Assets | 171,302 | ||
| Property and Equipment, Net | 498,348 | ||
| Right of Use Assets, Net | 243,371 | ||
| Intangible Assets, Net | 640,988 | ||
| Goodwill | 644,585 | ||
| Other Long-term Assets | 110,028 | ||
| Total Assets | $ | 2,455,880 | |
| Total Current Liabilities | $ | 129,439 | |
| Notes Payable, Net of Current Portion and Debt Discount | 254,504 | ||
| Lease Liability, Net of Current Portion | 249,446 | ||
| Other long-Term Liabilities | 115,684 | ||
| Total Equity | 1,706,807 | ||
| Total Liabilities and Equity | $ | 2,455,880 | |
| Green Thumb Industries Inc. Supplemental Information (Unaudited) Regarding Non-GAAP Financial Measures For the Three Months Ended September 30, 2022, June 30, 2022 and September 30, 2021 (Amounts Expressed in Thousands of United States Dollars) | ||||||||||||
| EBITDA, and Adjusted Operating EBITDA are non-GAAP measures and do not have standardized definitions under GAAP. We define each term as follows: | ||||||||||||
| (1) EBITDA is defined as earnings before interest, taxes, other income or expense and depreciation and amortization. | ||||||||||||
| (2) Adjusted Operating EBITDA is defined as earnings before interest, taxes, depreciation, and amortization, adjusted for other income, non-cash share-based compensation, one-time transaction related expenses, or other non-operating costs. | ||||||||||||
| The following information provides reconciliations of the supplemental non-GAAP financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with GAAP. The Company has provided the non-GAAP financial measures, which are not calculated or presented in accordance with GAAP, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with GAAP. These supplemental non-GAAP financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-GAAP financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-GAAP financial measures should not be considered superior to, as a substitute for or as an alternative to, and should be considered in conjunction with, the GAAP financial measures presented. | ||||||||||||
| Three Months Ended | ||||||||||||
| Adjusted Operating EBITDA | September 30, 2022 | June 30, 2022 | September 30, 2021 | |||||||||
| (Amounts Expressed in Thousands of United States Dollars) | (Unaudited) | (Unaudited) | (Unaudited) | |||||||||
| Net Income (Loss) Before Noncontrolling Interest (GAAP) | $ | 10,148 | $ | 24,731 | $ | 21,586 | ||||||
| Interest Income, Net | (1,085 | ) | (624 | ) | (328 | ) | ||||||
| Interest Expense, Net | 4,644 | 5,399 | 7,616 | |||||||||
| Income Taxes | 32,969 | 38,340 | 37,320 | |||||||||
| Other (Income) Expense, Net | 2,085 | (5,583 | ) | (8,125 | ) | |||||||
| Depreciation and Amortization | 24,518 | 24,198 | 17,173 | |||||||||
| Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) (Non-GAAP Measure) | $ | 73,279 | $ | 86,461 | $ | 75,242 | ||||||
| Share-based Compensation, Non-Cash | 7,878 | 6,833 | 4,995 | |||||||||
| Acquisition, Transaction, and Other Non-Operating Costs | 3,306 | (14,557 | ) | 944 | ||||||||
| Adjusted Operating EBITDA (Non-GAAP Measure) | $ | 84,463 | $ | 78,737 | $ | 81,181 | ||||||
FAQ
What were Green Thumb Industries' Q3 2022 financial results?
How much did Green Thumb's net income decline in Q3 2022?
What is the adjusted operating EBITDA for Green Thumb in Q3 2022?
What expansion plans did Green Thumb announce recently?
What is the current cash flow from operations for Green Thumb?
